Pharmacokinetics and safety of cicloprolol in uraemic patients.
J P
JP
Fillastre
M
M
Aparicio
C
C
Porquet
C
C
Dubruc
P
P
Rosenzweig
P L
PL
Morselli
D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use; D000787:Angina Pectoris / Q000150:complications / Q000188:drug therapy / Q000378:metabolism; D006207:Half-Life; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D011412:Propanolamines / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use; D014511:Uremia / Q000150:complications / Q000378:metabolism*
D000318:Adrenergic beta-Agonists; D011412:Propanolamines; C053708:cicloprolol